Axsome Therapeutics, Inc

AXSMNASDAQ • USD
141.79 USD
↗ 0.09 (0.07%)🟢PRE MARKET (AS OF 04:00 AM EST)
🟢Market: OPEN

Shares of Axsome Therapeutics, Inc (AXSM) are trading at $141.79. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, AXSM trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Nov 13, 2026.

Open?$141.79
High?$141.79
Low?$141.79
Prev. Close?$141.69
Volume?0
Avg. Volume?1.1M
Bid / Ask
Bid?$130.67 × 100
Ask?$152.67 × 100
Spread?$22.00
Midpoint?$141.67
Valuation & Ratios
Market Cap?7.5B
Shares Out?52.6M
Float?40.9M
Float %?78.1%
P/E Ratio?N/A
P/B Ratio?70.69
EPS?-$2.99
Dividend?0.00%
Ex-Dividend?N/A
RelatedJAZZ
News
Profile
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Employees
925
Market Cap
7.5B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-11-19
Address
ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK, NY 10007
Phone: (212) 332-3241
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
96
Momentum?
85
Short Sent.?
40
Piotroski F-Score?4/9Mixed
Altman Z-Score?4.53Safe
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.97%Elevated
Short Interest?3.3M
Days to Cover?3.4
Free Float40.9M
Avg Daily Volume975.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.42Adequate
Quick Ratio?1.34Adequate
Cash Ratio?0.62Adequate
Debt/Equity?1.87High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
50
S&P
3
70.69HIGH▾
P/S?
Peers
50
S&P
11
8.61HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
-50.9CHEAP▾
EV/Sales?
Peers
50
S&P
15
8.48HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
3
-149.2%WEAK▾
ROA?
Peers
50
S&P
3
-19.0%WEAK▾
Cash Flow & Enterprise
FCF?$-82613000
Enterprise Value?$7.3B
Fundamentals ratios updated end of day